| Filed On | Filing |
|---|---|
| 13 Sep 2023 |
8-K/A: Departure/Election of Directors or Officers; Compensation
As reported in the Original Form 8-K, effective as of August 21, 2023 (the “Termination Date”), Josh Lehrer, M.D., the former President, Chief Executive Officer and member of the Board of Directors of Graphite Bio, Inc. (the “Company”), ... |
| 13 Jul 2022 |
8-K/A: Other Events
Trial-in-progress poster of Phase 1/2 CEDAR trial evaluating GPH101 for sickle cell disease to be presented as an encore |
Loading...
